17 min listen
Mark Lythgoe on UK oncology drug approval after Brexit
Mark Lythgoe on UK oncology drug approval after Brexit
ratings:
Length:
14 minutes
Released:
Mar 27, 2023
Format:
Podcast episode
Description
Dr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit".Continue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Mar 27, 2023
Format:
Podcast episode
Titles in the series (100)
The Lancet Oncology: October 01, 2008 by The Lancet Oncology in conversation with